March 17, 2020 / 8:08 AM / 17 days ago

BRIEF-Vitrolife: Update Of Coronavirus's Impact On Vitrolife's Sales

March 17 (Reuters) - Vitrolife AB:

* UPDATE OF CORONAVIRUS’S IMPACT ON VITROLIFE’S SALES

* VITROLIFE ESTIMATES THAT SALES DURING Q1 WILL BE APPROXIMATELY IN LINE WITH LAST YEAR IN LOCAL CURRENCY AND THAT EBITDA MARGIN WILL AMOUNT TO APPROXIMATELY 33-37 PERCENT

* FURTHERMORE, COMPANY ASSESS THAT Q2 WILL BE SIGNIFICANTLY NEGATIVELY IMPACTED BY VIRUS OUTBREAK

* AND VITROLIFE EXPECTS A CONTINUOUSLY EXPANDING MARKET, WHICH IN MONETARY TERMS IS EXPECTED TO GROW BY 5-10 PER CENT PER YEAR FOR FORESEEABLE FUTURE

* IT IS DIFFICULT TO ESTIMATE HOW VIRUS OUTBREAK WILL AFFECT DEMAND FOR IVF TREATMENTS DURING Q2 OTHER THAN THAT IT WILL LIKELY HAVE A SIGNIFICANT NEGATIVE EFFECT Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below